CH Peptides
Every formulation is curated with lab-grade ingredients, and we're syncing up the freshest data from our inventory so you see accurate availability as soon as the app loads.
Loading live inventory
Syncing 24 research sprays
Verifying lab supplies
Supabase + Stripe ready
Orders placed before 2 P.M. PST Monday through Friday are shipped out same day!
Looks like you haven't added any products to your cart yet.
Loading...
BPC-157: Body Protection Compound-157, Peptide Fragment Derived from Human Gastric Juice. TB-500: Thymosin Beta-4 (TB4) Fragment, Research Code sometimes used interchangeably with a portion of Thymosin Beta-4.
BPC-157: A pentadecapeptide with the sequence Glu-Pro-Pro-Gly-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, consisting of 15 amino acids with a C-terminal amidation. TB-500: A shorter synthetic version of Thymosin Beta-4, typically referring to the sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Pro-Ala-Gly-Phe-Ser-Asp-Lys-D-Glu-P, with 20 amino acids.
BPC-157: Acts primarily by promoting angiogenesis and modulating growth factor pathways through interactions with VEGFR (Vascular Endothelial Growth Factor Receptors) and potentially GPCRs (G-protein coupled receptors). TB-500: Affects actin dynamics through G-actin binding, influencing cell motility and wound healing processes. Studies suggest involvement in PI3K/Akt signaling modulation.
BPC-157: Soluble in sterile water at up to 5mg/mL. Stable as a lyophilized powder; reconstituted solutions should be used within 24 hours when stored at 2-8°C. TB-500: Soluble in sterile water at concentrations up to 2mg/mL. Lyophilized form stable under normal laboratory conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
BPC-157: Body Protection Compound-157, Peptide Fragment Derived from Human Gastric Juice. TB-500: Thymosin Beta-4 (TB4) Fragment, Research Code sometimes used interchangeably with a portion of Thymosin Beta-4.
BPC-157: A pentadecapeptide with the sequence Glu-Pro-Pro-Gly-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, consisting of 15 amino acids with a C-terminal amidation. TB-500: A shorter synthetic version of Thymosin Beta-4, typically referring to the sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Pro-Ala-Gly-Phe-Ser-Asp-Lys-D-Glu-P, with 20 amino acids.
BPC-157: Acts primarily by promoting angiogenesis and modulating growth factor pathways through interactions with VEGFR (Vascular Endothelial Growth Factor Receptors) and potentially GPCRs (G-protein coupled receptors). TB-500: Affects actin dynamics through G-actin binding, influencing cell motility and wound healing processes. Studies suggest involvement in PI3K/Akt signaling modulation.
BPC-157: Soluble in sterile water at up to 5mg/mL. Stable as a lyophilized powder; reconstituted solutions should be used within 24 hours when stored at 2-8°C. TB-500: Soluble in sterile water at concentrations up to 2mg/mL. Lyophilized form stable under normal laboratory conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Chorionic Gonadotropin; commonly abbreviated as HCG. It is a glycoprotein hormone composed of alpha and beta subunits, predominantly characterized in human pregnancy. No specific research codes or development codes are associated with the basic glycoprotein.
HCG is a heterodimeric protein composed of two non-covalently linked subunits: the alpha subunit (92 amino acids) shared with other hormones like LH, FSH, and TSH, and the beta subunit (145 amino acids) which is unique to HCG. The beta subunit contains distinct segments: H-Trp-Met-Ser-Glu-His-Ile-Thr-Arg-Tyr-Leu-... and features specific disulfide bridges essential for activity and stability.
HCG acts as an agonist to the luteinizing hormone/chorionic gonadotropin receptor (LHCG receptor). Binding of HCG to its receptor activates pathways such as the cAMP/PKA signaling cascade, promoting steroidogenesis. EC50 values are variable based on assay and cellular system but are indicative of potent agonist activity.
HCG is soluble in sterile water at concentrations of 1mg/mL for research applications. Upon reconstitution, the solution must be stored at 2-8°C and is stable for up to 24 hours. Lyophilized HCG remains stable at -20°C until reconstitution.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Retatrutide is referred to by its research code LY3502970. As of current knowledge, alternative naming conventions in the literature have not been extensively established.
Retatrutide is a peptide compound consisting of 39 amino acids. The exact amino acid sequence is: H-Thr-Lys-Asp-Glu-Leu-Gln-Ala-Ile-Arg-Trp-Leu-Lys-His-Glu-Arg-Asp-His-Gly-Ile-Lys-Lys-Glu-Cys-Leu-Glu-Glu-Val-Leu-Asp-Ser-Leu-Ala-Arg-Ala-Glu-Glu-Arg-OH. Specific modifications include N-terminal acetylation and C-terminal amidation to enhance its activity and stability. It is structurally designed to interact with multiple peptide receptors.
Retatrutide acts as an agonist at multiple receptors, including the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), exhibiting multifaceted activity. Its mechanism enhances several intracellular signaling pathways, notably the cAMP/PKA and PI3K/Akt cascades. It demonstrates a unique binding profile, combining activities that influence metabolic pathways associated with glucose and lipid handling.
Retatrutide is notably soluble in sterile water at a concentration of 1mg/mL. For research applications, it is recommended to reconstitute the lyophilized form in an appropriate buffer and store it at -20°C to maintain stability. Once reconstituted, it remains stable for up to 3 weeks if stored under proper conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Retatrutide is referred to by its research code LY3502970. As of current knowledge, alternative naming conventions in the literature have not been extensively established.
Retatrutide is a peptide compound consisting of 39 amino acids. The exact amino acid sequence is: H-Thr-Lys-Asp-Glu-Leu-Gln-Ala-Ile-Arg-Trp-Leu-Lys-His-Glu-Arg-Asp-His-Gly-Ile-Lys-Lys-Glu-Cys-Leu-Glu-Glu-Val-Leu-Asp-Ser-Leu-Ala-Arg-Ala-Glu-Glu-Arg-OH. Specific modifications include N-terminal acetylation and C-terminal amidation to enhance its activity and stability. It is structurally designed to interact with multiple peptide receptors.
Retatrutide acts as an agonist at multiple receptors, including the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), exhibiting multifaceted activity. Its mechanism enhances several intracellular signaling pathways, notably the cAMP/PKA and PI3K/Akt cascades. It demonstrates a unique binding profile, combining activities that influence metabolic pathways associated with glucose and lipid handling.
Retatrutide is notably soluble in sterile water at a concentration of 1mg/mL. For research applications, it is recommended to reconstitute the lyophilized form in an appropriate buffer and store it at -20°C to maintain stability. Once reconstituted, it remains stable for up to 3 weeks if stored under proper conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.